Company Filing History:
3 out of 15 
1 out of 93 
Years Active: 2024-2025
Title: Seawon Ahn: Innovator in Cancer Treatment
Introduction
Seawon Ahn is a prominent inventor based in Seongnam-si, South Korea. He has made significant contributions to the field of cancer treatment through his innovative research and development of bispecific antibodies. With a total of three patents to his name, Ahn is recognized for his dedication to advancing medical science.
Latest Patents
Ahn's latest patents include the "Anti-HER2/anti-4-1BB bispecific antibody and use thereof." This invention provides a novel approach to treating and preventing cancer by utilizing a bispecific antibody that targets both HER2 and 4-1BB. Another notable patent is the "Anti-4-1BB antibody and use thereof," which describes an anti-4-1BB antibody or its antigen-binding fragment, along with its various applications in cancer therapy.
Career Highlights
Throughout his career, Seawon Ahn has worked with notable companies such as Abl Bio Inc. and Yuhan Corporation. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research in cancer treatment.
Collaborations
Ahn has collaborated with talented individuals, including Hyejin Chung and Eunyoung Park. These partnerships have fostered a creative environment that encourages innovation and the development of effective therapeutic solutions.
Conclusion
Seawon Ahn's work in the field of cancer treatment exemplifies the impact of innovative thinking and collaboration in medical research. His contributions through patents and partnerships continue to pave the way for advancements in cancer therapies.